No photo of Al B Benson III

View Scopus Profile

Al B Benson III

  • 29016 Citations
1984 …2018
If you made any changes in Pure these will be visible here soon.

Personal profile

Certifications and Licenses

1979Residency, Univ. of Wisconsin Hospital
1984Fellowship, Univ. of Wisconsin Hospital
Internal Medicine
Medical Oncology

Education/Academic qualification

MD, SUNY Buffalo

… → 1976

Keywords

  • Neuroendocrine Tumors
  • Stomach Cancer
  • Esophageal Cancer
  • Colon/Rectal Cancer
  • Liver Cancer
  • Anal Cancer
  • GI Stromal Tumors
  • Pancreatic Cancer
  • Gastrointestinal Malignancies

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 20 Similar Profiles
Colorectal Neoplasms Medicine & Life Sciences
Colonic Neoplasms Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2018

1 Citations

An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204)

Berlin, J. D., Feng, Y., Catalano, P., Abbruzzese, J. L., Philip, P. A., McWilliams, R. R., Lowy, A. M., Benson, A. B. & Blackstock, A. W., Jan 1 2018, In : Oncology (Switzerland). 94, 1, p. 39-46 8 p.

Research output: Contribution to journal › Article

gemcitabine
Research
Neoplasms
Disease-Free Survival
Therapeutics

First-line systemic treatment adherence, healthcare resource utilization, and costs in patients with gastrointestinal neuroendocrine tumors (GI NETs) in the USA

Broder, M. S., Cai, B., Chang, E., Yan, T. & Benson, A. B., Aug 3 2018, In : Journal of Medical Economics. 21, 8, p. 821-826 6 p.

Research output: Contribution to journal › Article

Neuroendocrine Tumors
Delivery of Health Care
Costs and Cost Analysis
Somatostatin
Drug Therapy
1 Citations

From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing

Trosman, J. R., Weldon, C. B., Gradishar, W. J., Benson III, A. B., Cristofanilli, M., Kurian, A. W., Ford, J. M., Balch, A., Watkins, J. & Phillips, K. A., Sep 1 2018, In : Value in Health. 21, 9, p. 1062-1068 7 p.

Research output: Contribution to journal › Article

Insurance Carriers
Neoplasms
Medicare
Technology
Precision Medicine
7 Citations

Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience

Salem, R. , Gabr, A. , Riaz, A. , Mora, R. , Ali, R. , Abecassis, M. , Hickey, R. , Kulik, L. , Ganger, D. , Flamm, S. , Atassi, R. , Atassi, B. , Sato, K. , Benson, A. B. , Mulcahy, M. F. , Abouchaleh, N. , Asadi, A. A. , Desai, K. , Thornburg, B. , Vouche, M. & 7 others Habib, A., Caicedo, J., Miller, F. H., Yaghmai, V., Kallini, J. R., Mouli, S. & Lewandowski, R. J., Oct 1 2018, In : Hepatology. 68, 4, p. 1429-1440 12 p.

Research output: Contribution to journal › Article

Liver Neoplasms
Hepatocellular Carcinoma
Confidence Intervals
Survival
Therapeutics
4 Citations

Marine v-3 polyunsaturated fatty acid and fish intake after colon cancer diagnosis and survival: CALGB 89803 (Alliance)

Van Blarigan, E. L., Fuchs, C. S., Niedzwiecki, D., Ye, X., Zhang, S., Song, M., Saltz, L. B., Mayer, R. J., Mowat, R. B., Whittom, R., Hantel, A., Benson, A., Atienza, D., Messino, M., Kindler, H., Venook, A., Ogino, S., Giovannucci, E. L. & Meyerhardt, J. A., Apr 1 2018, In : Cancer Epidemiology Biomarkers and Prevention. 27, 4, p. 438-445 8 p.

Research output: Contribution to journal › Editorial

Unsaturated Fatty Acids
Colonic Neoplasms
Fishes
Confidence Intervals
Survival